Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Aurobindo Pharma recalls Mirtazapine tablets in US over labelling error

      Aurobindo Pharma recalls Mirtazapine tablets in US over labelling error

      Medical Dialogues Bureau3 Jan 2020 1:07 PM IST
      Bottles labelled as Mirtazapine 7.5 mg may contain 15 mg tablets, as per Aurobindo Pharma's announcement posted on the website of the United States...
      Pacific Biosciences, Illumina cancel USD 1.2 billion deal

      Pacific Biosciences, Illumina cancel USD 1.2 billion deal

      Medical Dialogues Bureau3 Jan 2020 9:30 AM IST
      Gene sequencing company Illumina would pay Pacific Biosciences $98 million for the terminated deal, which was announced in 2018 and had attracted...
      MSN Labs subsidiary Novadoz Pharma gets USFDA nod for generic Uloric

      MSN Labs subsidiary Novadoz Pharma gets USFDA nod for generic Uloric

      Medical Dialogues Bureau3 Jan 2020 9:15 AM IST
      New Delhi: Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India, has received FDA approval...
      More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

      More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

      Medical Dialogues Bureau2 Jan 2020 2:48 PM IST
      New Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
      MorphoSys seeks USFDA nod for antibody Tafasitamab to treat lymphoma

      MorphoSys seeks USFDA nod for antibody Tafasitamab to treat lymphoma

      Medical Dialogues Bureau2 Jan 2020 12:14 PM IST
      New Delhi: MorphoSys AG announced recently that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA)...
      Walvax Biotechnology offers alternative to pneumonia drug Prevnar 13 in China

      Walvax Biotechnology offers alternative to pneumonia drug Prevnar 13 in China

      Medical Dialogues Bureau2 Jan 2020 9:20 AM IST
      Pfizer's Prevnar 13, which was approved in China in 2016, was the only pneumococcal 13-valent conjugate vaccine available around the world before...
      China rolls out drug extracted from brown algae to treat Alzheimers disease

      China rolls out drug extracted from brown algae to treat Alzheimers disease

      Medical Dialogues Bureau2 Jan 2020 9:15 AM IST
      Extracted from brown algae, the medicine is said to be the world’s first innovative therapy for the treatment of Alzheimer’s disease in 17 years,...
      Panacea Biotec hexavalent EasySix vaccine to cater to USD 1 billion market

      Panacea Biotec hexavalent EasySix vaccine to cater to USD 1 billion market

      Medical Dialogues Bureau31 Dec 2019 12:29 PM IST
      Panacea Biotec’s hexavalent vaccine, which can immunize patients against six diseases, including diphtheria, tetanus, hepatitis B and polio, will also...
      Universal Health Care Act presents opportunities for Indian pharma firms in Philippines: GlobalData

      Universal Health Care Act presents opportunities for Indian pharma firms in Philippines: GlobalData

      Medical Dialogues Bureau31 Dec 2019 9:45 AM IST
      India was found by the data analytics company to be the top import partner of the Philippines in 2018, contributing 12.6 per cent of the total...
      AstraZeneca-Merck Lynparza gets USFDA nod to treat pancreatic cancer

      AstraZeneca-Merck Lynparza gets USFDA nod to treat pancreatic cancer

      Medical Dialogues Bureau31 Dec 2019 9:30 AM IST
      Lynparza is already approved for ovarian and breast cancers, and its latest approval underscores the potential of PARP inhibitors for use in newer...
      Sol Gel Twyneo reduces acne marks in late-stage studies

      Sol Gel Twyneo reduces acne marks in late-stage studies

      Medical Dialogues Bureau31 Dec 2019 9:15 AM IST
      Sol Gel Technologies Ltd's Twyneo is a once-daily topical non-antibiotic cream containing a fixed-dose combination of encapsulated benzoyl peroxide...
      Rwanda to make own morphine to avoid US-style opioids crisis

      Rwanda to make own morphine to avoid US-style opioids crisis

      Medical Dialogues Bureau31 Dec 2019 9:00 AM IST
      New Delhi: It was something, the silence. Nothing but the scuff of her slip-on shoes as Madeleine Mukantagara walked through the fields to her first...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok